Marusak Thomas J

SEC source: 0001493152-26-027077 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,998,596

F1 · shares: Transaction reported is a grant of 849,556 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 100% upon the reporting person's separation from the issuer.

SEC source: 0001493152-25-026004 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149,040

F1 · shares: Transaction reported is a grant of 801,222 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 100% upon the reporting person's separation from the issuer.

SEC source: 0001641172-25-026264 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 347,818

F1 · shares: Transaction reported is a grant of 116,579 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on September 1, 2026, 33% on September 1, 2027, and 34% on September 1, 2028, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001641172-25-013458 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231,239

F1 · shares: Transaction reported is a grant of 86,512 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on June 1, 2026, 33% on June 1, 2027, and 34% on June 1, 2028, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001641172-25-012074 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,727

SEC source: 0001493152-24-048561 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,718

F1 · shares: Transaction reported is a grant of 43,044 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on December 1, 2025, 33% on December 1, 2026, and 34% on December 1, 2027, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001493152-24-035055 · ownership.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,674

F2 · shares: Transaction reported is a grant of 42,568 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001493152-24-035055 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,106

F1 · shares: Transaction reported is a grant of 3,453 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% immediately, 33% on June 1, 2025, and 34% on June 1, 2026, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001493152-24-022844 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,653

F1 · shares: Transaction reported is a grant of 5,981 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee.The shares of Common Stock will vest 33% on June 1, 2024, 33% on June 1, 2025, and 34% on June 1, 2026, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001493152-24-015101 · ownership.xml · derivative · entry 4

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,125 shares

Expires 2027-11-22

F4 · price: On April 15, 2024, the stock options were cancelled by mutual agreement of the reporting person and the issuer.

F3 · derivative.exercise_date: All shares of Common Stock subject to this stock option were vested and exercisable on the date of cancellation.

SEC source: 0001493152-24-015101 · ownership.xml · derivative · entry 3

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,064 shares

Expires 2026-05-13

F4 · price: On April 15, 2024, the stock options were cancelled by mutual agreement of the reporting person and the issuer.

F3 · derivative.exercise_date: All shares of Common Stock subject to this stock option were vested and exercisable on the date of cancellation.

SEC source: 0001493152-24-015101 · ownership.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,672

F2 · shares: Transaction reported is a grant of 41,176 restricted stock awards representing shares of Common Stock, which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on June 1, 2024, 33% on June 1, 2025, and 34% on June 1, 2026, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001493152-24-015101 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,977

F1 · shares: Transaction reported is a grant of 52,977 restricted stock awards representing shares of Series A Cumulative Perpetual Preferred Stock, par value $0.001 per share, of the issuer ("Preferred Stock"), which were approved by the Compensation Committee. The shares of Preferred Stock will vest 100% upon the reporting person's separation from the issuer.

SEC source: 0001493152-22-033629 · ownership.xml · derivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,850

Underlying: Common Stock · 78,125 shares

Expires 2027-11-22

F1 · derivative.exercise_price: The stock options were received as compensation for their services on the Board of Directors in lieu of quarterly cash payments for September 30, 2022 and December 31, 2022. The options become exercisable in two equal installments, 50% immediately and 50% on December 31, 2022. The stock options expire five years from the grant date. The exercise price is based on a 25% premium on the closing price of SLNH common stock as of 11/22/2022.

F1 · derivative.exercise_date: The stock options were received as compensation for their services on the Board of Directors in lieu of quarterly cash payments for September 30, 2022 and December 31, 2022. The options become exercisable in two equal installments, 50% immediately and 50% on December 31, 2022. The stock options expire five years from the grant date. The exercise price is based on a 25% premium on the closing price of SLNH common stock as of 11/22/2022.

F1 · derivative.expiration_date: The stock options were received as compensation for their services on the Board of Directors in lieu of quarterly cash payments for September 30, 2022 and December 31, 2022. The options become exercisable in two equal installments, 50% immediately and 50% on December 31, 2022. The stock options expire five years from the grant date. The exercise price is based on a 25% premium on the closing price of SLNH common stock as of 11/22/2022.

SEC source: 0001753926-22-001108 · ownership.xml · derivative · entry 4

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

Underlying: Common Stock · 9,375 shares

Expires 2028-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On December 12, 2018, the reporting person was granted options to purchase 12,500 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 9,375 shares of common stock were vested and options to purchase 3,125 shares of common stock remain unvested.

F2 · balance_after: On December 12, 2018, the reporting person was granted options to purchase 12,500 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 9,375 shares of common stock were vested and options to purchase 3,125 shares of common stock remain unvested.

SEC source: 0001753926-22-001108 · ownership.xml · derivative · entry 3

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2025-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On March 5, 2015, the reporting person was granted options to purchase 19,000 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 19,000 shares of common stock were vested.

F1 · balance_after: On March 5, 2015, the reporting person was granted options to purchase 19,000 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 19,000 shares of common stock were vested.

SEC source: 0001753926-22-001108 · ownership.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001753926-22-001108 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001753926-22-001128 · ownership.xml · derivative · entry 4

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

Underlying: Common Stock · 9,375 shares

Expires 2028-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On December 12, 2018, the reporting person was granted options to purchase 12,500 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 9,375 shares of common stock were vested and options to purchase 3,125 shares of common stock remain unvested.

F3 · balance_after: On December 12, 2018, the reporting person was granted options to purchase 12,500 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 9,375 shares of common stock were vested and options to purchase 3,125 shares of common stock remain unvested.

SEC source: 0001753926-22-001128 · ownership.xml · derivative · entry 3

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2025-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On March 5, 2015, the reporting person was granted options to purchase 19,000 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 19,000 shares of common stock were vested.

F2 · balance_after: On March 5, 2015, the reporting person was granted options to purchase 19,000 shares of common stock of the issuer, which vest in four equal annual installments beginning on the first anniversary of the grant date. As of August 18, 2022, options to purchase 19,000 shares of common stock were vested.

SEC source: 0001753926-22-001128 · ownership.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This corrects Mr. Marusak's Form 4 filed on August 22, 2022, which inadvertently reported the incorrect number of shares of common stock acquired by Mr. Marusak upon the exercise of his options due to a typographical error. The correct beneficial ownership was reported in Column 5.

SEC source: 0001753926-22-001128 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001753926-22-000088 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,025

F1 · shares: Transaction reported is a grant of 20,500 and 20,500 restricted stock units representing shares (the "2022 Grant") of common stock, par value $0.001 per share, of the issuer (the "Common Stock") received as compensation for the reporting person's service as a member of the issuer's board of directors and as chair of the compensation committee of the board of directors, respectively. The shares of Common Stock subject to the 2022 Grant vest as follows: 37% vests 12 months from the date of the grant, or January 14, 2023, 33% vests 24 months from the date of the grant, or January 14, 2024, and 30% vests 36 months from the date of the grant, or January 14, 2025, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

SEC source: 0001753926-21-000514 · ownership.xml · derivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,000 shares

Expires 2024-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Stock option grant for annual board service.

F2 · derivative.exercise_date: The option is fully vested

SEC source: 0001753926-21-000514 · ownership.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001312027-21-000005 · primary_doc.xml · derivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,100

Underlying: Common Stock · 26,600 shares

Expires 2026-05-13

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer.

SEC source: 0001312027-21-000004 · primary_doc.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,025

SEC source: 0001312027-21-000001 · primary_doc.xml · derivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,733

Underlying: Common Stock · 7,732 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The reporting person was granted 15,465 shares of restricted stock on January 14, 2020, of which 7,732 vested on January 14, 2021, as reported in Table I on this Form 4. The remaining unvested shares of common stock will vest on January 14, 2022, assuming the reporting person is a director of the Issuer on such date.

F1 · derivative.expiration_date: The reporting person was granted 15,465 shares of restricted stock on January 14, 2020, of which 7,732 vested on January 14, 2021, as reported in Table I on this Form 4. The remaining unvested shares of common stock will vest on January 14, 2022, assuming the reporting person is a director of the Issuer on such date.

SEC source: 0001312027-21-000001 · primary_doc.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001003297-18-000090 · primary_doc.xml · derivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2022-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001003297-18-000090 · primary_doc.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,560

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001003297-17-000173 · marusak.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,060

SEC source: 0001003297-17-000173 · marusak.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,015

SEC source: 0001003297-17-000164 · marusak.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,965

SEC source: 0001003297-16-000890 · marusak.xml · nonDerivative · entry 2

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,875

SEC source: 0001003297-16-000890 · marusak.xml · nonDerivative · entry 1

Marusak Thomas J · CIK 0001312027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,875